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Background: Clinical laboratory personnel, like all healthcare workers, have a high 
risk of occupational exposure to blood-borne infections from clinical specimens, 
more so in developing countries, where unsafe practices are common. The most 
common and important ones are HIV ,HBV, and HCV infections.  
Objectives: To determine the sero-prevalence of HIV, HBV and HCV infections in 
blood samples at a clinical laboratory, and to address the preventive measures. 
Methods: Blood samples of 385 subjects attended for investigations of 
noninfectious illnesses were tested for the  seroprevalence of HIV, HBV, and HCV 
by screening tests and confirmed by ELISA.   
Results: Males constituted 63.9%, HIV was confirmed in 0.5%, HBV in 7.8% and 
HCV in none of the study population.  
Conclusion: The risk of blood borne viral disease in blood specimens is remarkable 
even in non-suspected specimens and protective measures against occupational 
exposure must be taken in order to prevent infection among laboratory  workers.  
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 :صخلملا 
  لمعملاب مدلا تانيع يف بستكملا ةعانملا زوع سوريفو "ج" و "ب" دبكلا باهتلا يسوريف راشتنا
 نادوسلاب ةربطع ةنيدم يفيبطلا 
 : ةمدقم عم لاحلا وه امك, ةيبطلا لماعملاب نولماعلا ضرعتي ةباصلإا رطاخم يلإ ,ةحصلاب نيلماعلا ةيقب
 هذه مهأو .ةملاسلا تاءارجإ لقت ثيح ةيمانلا لودلا يف ةصاخبو مدلا قيرط نع ةلوقنملا ضارملأاب
.ةعانملا زوعو دبكلا باهتلا تاسوريف يه ضارملأا  
 :فادهلأافو "ج" و "ب" دبكلا باهتلا يسوريف راشتنا ةبسن ديدحت يلإ ةسرادلا هذه تفدهع سوري زو
 .ةياقولا لبس زاجيإ مت امك ,يبطلا لمعملاب مدلا تانيع يف بستكملا ةعانملا 
قرطلاو ىضرملا ءاقتنا مت :385  ةعيبط تاذ تسيل ضارعأب ىضرمل مد ةنيع  ةيئاودع
.تاسوريفلا نع ةيديكأتلاو ةيحسملا تاصوحفلل تعضخأو  
جئاتنلا%  ةبسن روكذلا لكش :63.9 ف راشتنا ةبسن تناكو%  ةبستكملا ةعانملا زوع سوري0.5 
% "ب" دبكلا باهتلاسوريفو7.8 .ةساردلا ةنيع يف "ج" دبكلا باهتلا سوريفب ةباصإ ةيأ ددحت ملو  
ةمتاخ مدع لظ يف ىتح ةيبطلا لماعملاب نيلماعلا يلع ارطخ مدلا قيرط نع ةلوقنملا ضارملأا لكشت :
 ريبادتلا ذاختا بجيو ةنيعلا يف هابتشا دوجو .ةباصلإا يدافتل ةمزلالا ةملاسلا تاطايتحاو 
  
Background:  
Healthcare workers have a high risk of occupational exposure, more so in 
developing countries, with high incidence of blood borne diseases and prevalence of 
unsafe practices. Among the various blood borne diseases, the most common and 
important infections are HIV, hepatitis B and hepatitis C.(1) Hepatitis B continues to 
be a major risk to health care workers, killing approximately 200 per year in USA. 
In contrast, as of 1990, only 327 total health care personnel had acquired HIV, with 
no deaths reported. Data are lacking regarding hepatitis C, but it appears to be an 
increasing concern. Needle pricks are the most common form of occupational 
transmission, with an infectivity rate of 30% for hepatitis B, 3% for hepatitis C, and 
0.3% for HIV.  
Universal precautions are the cornerstones of safety. (2)   
The economic costs of the failure to control the transmission of infection include 
increased requirement for medical care, higher levels of dependency and the loss of 
productive labor force, placing heavy burdens on already overstretched health and 
social services and on the national economy. (3, 4)   
Prevention of occupational exposure is dependent on education. Prevention 
strategies include immunization, exposure avoidance by the use of universal 
precautions at all times, and post-exposure advice and prophylaxis.(5)  
 Recommendations for HBV post-exposure management include initiation of the 
hepatitis B vaccine series to any susceptible, unvaccinated person who sustains an 
occupational blood or body fluid exposure. Post-exposure prophylaxis (PEP) with 
hepatitis B immune globulin (HBIG) and/or hepatitis B vaccine series should be 
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considered for occupational exposures after evaluation of the hepatitis B surface 
antigen status of the source and the vaccination and vaccine-response status of the 
exposed person. Guidance is provided to clinicians and exposed health care 
personnel (HCP) for selecting the appropriate HBV PEP. Immune globulin and 
antiviral agents (e.g., interferon with or without ribavirin) are not recommended for 
PEP of hepatitis C. For HCV postexposure management, the HCV status of the 
source and the exposed person should be determined, and for HCP exposed to an 
HCV positive source, follow-up HCV testing should be performed to determine if 
infection develops. Recommendations for HIV PEP include a basic 4-week regimen 
of two drugs (zidovudine [ZDV] and lamivudine [3TC]; 3TC and stavudine [d4T]; 
or didanosine [ddI] and d4T) for most HIV exposures and an expanded regimen that 
includes the addition of a third drug for HIV exposures that pose an increased risk 
for transmission.(6)  
Patients and Methods:  
Study subjects:   
Patients who presented to the Modern Specialized Laboratory (MSL) with a request 
for blood investigations for a non-infectious condition during the period from the 
1st of June to the 2nd of August and volunteered to participate were included. The 
MSL is a private pathologist-managed laboratory. Atbara is 310 km north to 
Khartoum, with a total population of 134,586.  
 The biodata of all patients were obtained by closed ended pre-tested questionnaire 
that also included risk factors and knowledge about methods of transmission. All 
patients were offered pre- and post-test counseling and an informed consent was 
obtained.   
Criteria for exclusion were:  age less than 15 years, fever at time of presentation, 
hemophilia, sickle cell anemia, patients on hemodialysis, patients who refuse to 
volunteer (no penalty imposed on them) and patients with a request for either an 
infectious disease or an indirect marker of infection e.g. liver enzymes.  
Sample collection  
Five milliliters of venous blood were collected from each subject by clean 
venipuncture, dispensed into a clean dry glass test-tube and allowed to clot naturally 
at room temperature. The clotted blood samples were then spun in a centrifuge at 
2500 rpm for 5 minutes to separate the serum which was used for the analysis of the 
requested investigation as well as viral screening tests. Sera that reacted positive 
was refrigerated and used for the confirmatory ELISA test.  
Serological analysis  
Hepatitis B surface antigen (HBsAg), antibodies to HCV and HIV1and HIV2 were 
detected using Ultra Rapid Test Device (ACON® Laboratories, Inc. USA). All the 
reactive samples were confirmed using enzyme-linked immunosorbent assay 
(ELISA) kits (Human®, Germany). The manufacturers’ standard operating 
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procedures were strictly followed for the performance of all tests. Statistical 
methods  
The data generated were coded, entered, validated and analyzed using Statistical  
Package for Social Science (SPSS) version 12.0. The sero-prevalences of HBsAg, 
HCV and HIV were expressed for the entire study group and by age, sex and risk 
factors. P-values below 0.05 were considered statistically significant. Ethical issues  
A written informed consent was obtained prior to enrollment. The following 
information was given during patient education to ensure that patients have the 
information needed to make an informed choice; a complete description of the aims 
of the study, infectious agents that were being screened, potential benefits and risks, 
blood collection procedures and assurance of confidentiality of any information 
given as well as test results. Any other requested additional information was 
provided to patients by study personnel. Subjects who were found to have any of the 
screened pathogens were referred, according to their desire, to a physician clinic 
where additional investigations and appropriate management and follow-up were 
given. All participants' information and test results were confidentially kept.  
  
Results:   
A total of 385 patients were selected 246 (63.9%) males, (139)36.1% females. Most 
(64.7%) were in the age range of 26 - 45 years, (15.3%) were illiterates and most 
(62.3%) were married . Rapid screening tests were reactive in 2.6% for HIV, 7.8% 
for HBV and 0.3% for HCV. For the confirmatory ELISA test, seropositivity was 
0.5% for HIV, 7.8% for HBV and 0.0% for HCV. Eighty-two percent of 
participants  did not know the mode of transmission of viral hepatitis in comparison 
to 26.5% for HIV. 13.2% gave a history of genital disease. No significant statistical 
difference was observed with any of the following risk factors: sex, marital status, 
history of blood transfusion or surgical operation.  
Discussion:  
Clinical laboratory workers are in direct contact with blood specimens on daily 
basis. The risk of getting infected by a serious viral disease is under estimated by 
many of them, especially when there is lack of information regarding the prevalence 
of blood borne pathogens in the local community they serve. The risk is aggravated 
by the low awareness about the universal safety precautions and absence of post-
exposure prophylaxis strategies.  
The aim of this study is to determine the prevalence of the common blood borne 
viruses: HIV, HBV and HCV in blood specimens in patients not suspected to have a 
viral disease, i.e. apparently non-infectious samples, which are usually handled with 
less care.  
The male to female ratio was 1.8 to 1.0. Males seem to be more willing to volunteer 
and spend some time responding to a questionnaire. But sex did not constitute a risk 
factor for any of the tested infections.  While only 26.5% did not know the mode of 
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transmission of HIV, 82% did not know how viral hepatitis is transmitted. This may 
be due to tremendous efforts exerted to raise the awareness about HIV but not viral 
hepatitis. At the same time viral hepatitis is more prevalent in our communities with 
more serious consequences in terms of morbidity and economy.  
HIV infection was confirmed in 2 patients (0.5%) by ELISA i.e only 25% of the 
rapid test positive cases (n=8). The rapid tests are used in our blood banks and 
routine clinical laboratories, this may shed light on how much blood donors we 
unnecessarily rejected and donated blood discarded creating panic and suffering. 
The (0.5%) result of HIV positivity is similar to that reported from west Sudan  
(0.8%). (7)   
Prevalence of HBV in this study (7.8%) was lower than that reported from South  
(26%) (8) and West (10%) Sudan (7). But higher than reports from Shendi (North) 
(5.1%) (9) and Gezira (central Sudan) (5.6%) (10). The prevalence of HCV (0.0%) 
was in agreement with that reported from west Sudan (7). The highest prevalences of 
HCV were found in African countries and the Middle East (11-13), while the lowest 
prevalence rate was recorded in England (0.1%). (14)   
This study, as for studies in blood donors, does not represent the true prevalence of 
diseases in the community because the sample is selected.   
  
  
Conclusion:   
The seroprevalence of blood-borne pathogens detected in this study calls for 
mandatory screening for HBV, HIV and HCV in the whole population. ELISA may 
be the optimal tool for screening. Protective measures against occupational exposure 
to the hepatitis viruses and HIV must be taken in order to prevent infection in 
laboratory and health care workers.  
HBV vaccination should be made compulsory for all laboratory workers.  
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